Acupuncture in the real world: evaluating a 15-year NADA auricular acupuncture service for breast cancer survivors experiencing hot flushes and night sweats as a consequence of adjuvant hormonal therapies.

Breast cancer survivors taking hormone therapy often experience uncomfortable hot flushes and night sweats that can significantly impact quality of life. This study evaluated a real-world acupuncture service that treated these symptoms over 15 years using a standardized ear acupuncture technique called the NADA protocol. Researchers analyzed data from 415 women referred to the service, with 300 receiving treatment and 275 completing all eight sessions. The women tracked their symptoms using daily diaries and completed questionnaires about their menopausal symptoms at the start of treatment, at the end, and at follow-ups 4 and 18 weeks later. Results showed that the average number of hot flushes and night sweats dropped from about 10 per day to approximately 6 per day by the end of treatment, with benefits lasting at least 18 weeks after treatment ended. Women also reported meaningful improvements in how much these symptoms bothered them, with problem ratings decreasing by at least 2 points on a standardized scale. Additional benefits included improvements in other menopause-related symptoms like sleep problems, anxiety, and overall well-being. The treatment was very safe, with only two minor side effects reported over more than 2,285 treatment sessions. These real-world results matched findings from controlled research studies, suggesting that ear acupuncture using the NADA protocol can be an effective and safe option for managing treatment-related hot flushes in breast cancer survivors. If you're considering acupuncture for these symptoms, seek a qualified, licensed acupuncturist with experience treating oncology patients.

This service evaluation analyzed 15 years of clinical data from 415 breast cancer survivors referred for auricular acupuncture to manage adjuvant hormone therapy-induced vasomotor symptoms. Three hundred women received treatment using the standardized NADA protocol over eight sessions; 275 (92.3%) completed the full course, representing over 2,285 treatments. Primary outcomes included hot flush diaries, Hot Flush Rating Scale (HFRS), and Women's Health Questionnaire (WHQ) administered at baseline, end of treatment (EOT), and 4- and 18-week follow-ups. Median daily HFNS frequency decreased from 9.6 (IQR 7.3) at baseline to 5.7 (IQR 5.8) at EOT and 6.3 (IQR 6.5) at 18 weeks post-treatment. HFRS problem ratings demonstrated clinically meaningful reductions of ≥2 points sustained through all measurement points. WHQ showed improvements across multiple menopause-associated domains. Two non-serious adverse events were documented. Clinical takeaway: Real-world implementation of the NADA auricular protocol demonstrates comparable efficacy to controlled trials, with sustained symptom reduction and excellent safety profile for managing treatment-induced vasomotor symptoms in breast cancer survivors.